Back to UBS Group AG UBS Group AG

ALLRALLR
8 quarters

Position history for UBS Group AGUBS Group AG's holdings in ALLARITY THERAPEUTICS INC

Yes. Ubs holds 26,589 shares of ALLR (Allarity Therapeutics), worth $34,300, as of its Q2 2026 13F filing. It increased the position by 3,431 shares (+14.8%) from Q1 2026. Ubs has held ALLR since Q4 2025, across 3 quarterly 13F filings.

Current Value

$34,300

Current Shares

26,589

Total Value Change

-$4,634

Total Shares Change

+8,137

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
26,589
+14.8%
$34,3000.0%$1.29
15
2026-Q1
Decreased
23,158
-12.7%
$25,2420.0%$1.09
0
2025-Q4
New
26,516
-
$28,6370.0%$1.08
30
2025-Q3
Exited
0
-100.0%
$00.0%$1.58
0
2025-Q2
Increased
47,984
+159x
$48,4640.0%$1.01
22
2025-Q1
New
300
-
$2810.0%$0.94
17
2024-Q4
Exited
0
-100.0%
$00.0%$1.17
0
2024-Q3
New
18,452
-
$38,9340.0%$2.11
31

Other major holders of ALLR: Private Advisor Group, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used